Rock Springs Capital Management LP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 120 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.5%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2020$18,199,000
+27.2%
288,279
+3.0%
0.50%
-15.6%
Q1 2020$14,305,000
-32.1%
280,000
+5.7%
0.59%
-11.3%
Q4 2019$21,065,000
+63.8%
265,0000.0%0.67%
+30.1%
Q3 2019$12,858,000
-7.8%
265,0000.0%0.51%
+1.6%
Q2 2019$13,939,000
+7.5%
265,000
+8.2%
0.50%
+0.8%
Q1 2019$12,968,000
+28.9%
245,0000.0%0.50%
+5.3%
Q4 2018$10,057,000
+76.4%
245,000
+63.3%
0.48%
+130.6%
Q3 2018$5,700,000
-15.9%
150,0000.0%0.21%
-21.1%
Q2 2018$6,780,000
-6.4%
150,0000.0%0.26%
-15.5%
Q1 2018$7,245,000
+22.7%
150,0000.0%0.31%
+15.3%
Q4 2017$5,903,000
+26.7%
150,0000.0%0.27%
+24.7%
Q3 2017$4,658,000
+13.5%
150,0000.0%0.22%
+3.9%
Q2 2017$4,103,000
-25.8%
150,0000.0%0.21%
-35.1%
Q1 2017$5,528,000
+296.6%
150,000
+55.4%
0.32%
+243.0%
Q4 2016$1,394,000
-38.3%
96,500
-1.5%
0.09%
-34.5%
Q3 2016$2,259,000
+38.9%
98,0000.0%0.14%
+18.3%
Q2 2016$1,626,000
+31.4%
98,000
+25.6%
0.12%
+15.4%
Q1 2016$1,237,000
-45.7%
78,000
+10.6%
0.10%
-39.9%
Q4 2015$2,279,000
-9.9%
70,500
+17.5%
0.17%
-15.6%
Q3 2015$2,530,00060,0000.20%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders